PhRMA Testing Pilot Framework For Structured Benefit-Risk Assessment

The Pharmaceutical Research and Manufacturers of America’s Benefit-Risk Action Team expects to complete pilot testing of a framework for conducting benefit-risk assessments by the end of 2011.